Thiotepa 65219-0029
Product NDC
65219-0029- Manufacturer
- Fresenius Kabi Usa, Llc
- Dosage Form
- Injection, Powder, Lyophilized, For Solution
- Route
- Intracavitary, Intravenous, And Intravesical
- Product Type
- Human Prescription Drug
- Marketing Start
- April 11, 2022
- Listing Expires
- December 31, 2026
- Application
- ANDA214222
Need to source Thiotepa? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.
Active Ingredients
| Ingredient | Strength |
|---|---|
| Thiotepa | 100 mg/1 |
Drug Class
Alkylating Drug [EPC]Alkylating Activity [MoA]Alkylating Drug [EPC]
Packaging Options(1)
1 VIAL in 1 CARTON (65219-029-20) / 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 VIAL